Sun Pharma’s NDA for Deuruxolitinib garners FDA nod: A potential leap for alopecia areata patients

Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their investigational drug, ... Read More